CAS: 464-92-6; (1S,2R,4As,6As,6Br,8Ar,9R,10R,11R,12Ar,12Br,14Bs)-10,11-Dihydroxy-9-(Hydroxymethyl)-1,2,6A,6B,9,12A-Hexamethyl-1,3,4,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Octadecahydropicene-4A(2H)-Carboxylic Acid

该化合物是一种天然衍生的三丁基类化合物,具有强效抗炎特性,已发现抑制NF-B活化和COX-2表达方式,展示了它作为皮肤护理和皮肤学应用热剂中有价值的成分的潜力,特别是在减少炎症和促进伤口愈合方面.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报

上下游产品

CAS号16830-15-2 积雪草苷

合成工艺路线路线简述

    积雪草苷置于甲醇,Sodium Hydroxide体系中,化学反应生成 积雪草酸
    参考文献:含有[小α]-氨基膦酸酯的新型积雪草酸衍生物的合成,抗增殖和诱导细胞凋亡的作用
    标题:含有[小α]-氨基膦酸酯的新型积雪草酸衍生物的合成,抗增殖和诱导细胞凋亡的作用
    摘要:这是已接受的手稿,已通过rsc出版同行评审过程,并已被接受出版.接受的手稿在接受后不久就会在线发布.一旦可用,此版本的文章将被完全编辑,格式化并提供高级阅读的高级文章代替.
    DOI:10.1039/c6Ra11397D

    海关参考信息

    专利信息


    专利号:US-5955083-A
    优先权日:1996-01-03
    标 题 :Use of eriobotrya japonica extract, in particular in cosmetics for stimulating glycosaminoglycan synthesis
    发明人:BONTE FREDERIC; DUMAS MARC
    权利人:LVMH RECH
    摘要:PCT No. PCT/FR97/00009 Sec. 371 Date Aug. 28, 1997 Sec. 102(e) Date Aug. 28, 1997 PCT Filed Jan. 3, 1997 PCT Pub. No. WO97/06659 PCT Pub. Date Feb. 27, 1997The invention concerns novel uses of an Eriobotrya japonica extract, in particular in cosmetics or pharmaceutics. This extract permits stimulation of glycosaminoglycan synthesis, in particular of hyaluronic acid, thus imparting to the cosmetic compositions containing this extract the properties of improving the firmness and suppleness of the skin, combating the formation of wrinkles or lessening the depth thereof, smoothing the surface of the skin by means of a tightening effect, or moisturizing the skin. The invention further concerns the use of these extracts for stimulating the synthesis of glycosaminoglycans from a cell culture medium, in particular fibroblasts or keratinocytes.

    专利号:US-2023157936-A1
    优先权日:2021-11-24
    标 题 :Anti-aging skin peel composition and method of application
    发明人:ZAHR ALISAR; NGUYEN THU Q; KOCH JOHN; KELLY TATIANA
    权利人:JAMRM LLC
    摘要:A skincare composition and a method for removing layers of skin in a cosmetic procedure. The skincare composition comprises active ingredients mixed into a cosmetically acceptable carrier. The active ingredients include an effective amount of one or more keratolytic agents for inducing a desired degree of keratolysis in the skin, an effective amount of one or more free radical neutralizing agents for negating cellular damage from reactive chemical species, and an effective amount of one or more agents increasing synthesis of dermal components. The one or more free radical neutralizing agents and the one or more agents increasing synthesis of dermal components are acids in their un-neutralized, natural acid form, and a total amount of the active ingredients is less than 50 w/w% of the skincare composition, and a pH of the skincare composition is between 1.5-3.5.

    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    专利号:US-2022162188-A1
    优先权日:2019-01-15
    标 题:Isoprenoids and methods of making thereof
    发明人:WILLIAMS GAVIN; LUND SEAN; HALL RACHAEL
    权利人:UNIV NORTH CAROLINA STATE
    摘要:Disclosed are methods for preparing isoprenoid subunits, as well as methods of employing these isoprenoid subunits for the synthesis of isoprenoids. Also provided are isoprenoids prepared using the methods described herein.

    专利号:US-5747538-A
    优先权日:1994-03-18
    标 题 :Use of ginsenoside R0 or a plant extract containing same to promote collagen synthesis
    发明人:MEYBECK ALAIN; BONTE FREDERIC; DUMAS MARC; CHAUDAGNE CATHERINE
    权利人:LVMH RECH
    摘要:PCT No. PCT/FR95/00326 Sec. 371 Date Sep. 18, 1996 Sec. 102(e) Date Sep. 18, 1996 PCT Filed Mar. 17, 1995 PCT Pub. No. WO95/25524 PCT Pub. Date Sep. 28, 1995The use of ginsenoside R0 or a plant extract containing same to prepare a cosmetic or pharmaceutical composition, particularly a skin care composition, for promoting collagen synthesis, particularly collagen I and/or collagen III synthesis. Said cosmetic or pharmaceutical composition is administered to a mammal, particularly a human being, in order to promote collagen synthesis. A method for promoting collagen synthesis in fibroblast growth media is also disclosed.

    专利号:US-2024301461-A1
    优先权日:2023-01-17
    标题:Recombinant Escherichia Coli for Expressing Synthesis Pathway of Asiaticoside and Application Thereof
    发明人:ZHOU JINGWEN; ZENG WEIZHU; ZHAO XINGYING; XU SHA; CHEN JIAN
    权利人:UNIV JIANGNAN
    摘要:The present disclosure discloses recombinant Escherichia coli for expressing a synthesis pathway of asiaticoside and application thereof, and belongs to the field of bioengineering. Rhamnosyltransferase with an amino acid sequence shown in any one of SEQ ID NO: 25 to SEQ ID NO: 29, glucosyltransferase with an amino acid sequence shown in any one of SEQ ID NO: 10 to SEQ ID NO: 17 and UGT73AH1 reported in a document are transferred into E. coli BL21 (DE3)Δpgi to realize co-expression. Fermentation results show that all 5 rhamnosyltransferases screened in the present disclosure can achieve effects, and a unique new peak appears at 0.596 min, which is consistent with a characteristic ion flow of an asiaticoside standard product. According to the present disclosure, barriers of the prior art are broken through, a new biosynthesis method for asiaticoside is provided, and industrialization of biosynthesis of asiaticoside becomes possible.
    西安绿天生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.plamed-extract.com
    电话: 400-992-1768👤
    📞西安绿天生物技术有限公司 ⚠️参考联系方式

    销售电话:400-992-1768
    邮箱:sales@plamed.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海高又高化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.angoal.com
    电话: 0086 21 5835 8698👤
    📞上海高又高化工有限公司 ⚠️参考联系方式

    销售电话:0086 21 5835 8698
    邮箱:info@angoal.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市浦东新区东建路670弄2号1804室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    陕西帕尼尔生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.pioneerbiotech.com
    企业联系电话:029-84385017-8001👤
    📞陕西帕尼尔生物科技有限公司 ⚠️参考联系方式
    联系人:高经理;肖经理
    电话:029-84385017-8001
    手机:高经理13259417953
    传真:QQ:1477918929
    邮箱:sales5@pioneebiotech.com
    通信地址: 陕西省西安市未央区凤城十路保利中达广场
    邮编: 710000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:陕西省西安市未央区凤城十路保利中达广场
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    杭州易合生物医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hz-yihe.com
    企业联系电话:13758158578👤
    📞杭州易合生物医药科技有限公司 ⚠️参考联系方式
    联系人:王经理
    电话:13758158578
    手机:13758158578;;18058808578
    传真:0571-88737015
    邮箱:sales@hz-yihe.com wangkemm@163.com
    通信地址: 浙江省杭州市余杭区华夏之心(联创街与海鸥路交叉口)19幢2006室
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省杭州市余杭区华夏之心(联创街与海鸥路交叉口)19幢2006室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Chen R, Zhang W, Zhang M, Liu W, Feng W, Zhang Y. Asiatic acid in anticancer effects: emerging roles and mechanisms. Front Pharmacol. 2025 Feb 24;16:1545654. doi: 10.3389/fphar.2025.1545654.
    2: Liang C, Ma Y, Ding M, Gao F, Yu K, Wang S, Qu Y, Hua H, Li D. Asiatic acid and its derivatives: Pharmacological insights and applications. Eur J Med Chem. 2025 Feb 23;289:117429. doi: 10.1016/j.ejmech.2025.117429. Epub ahead of print. 17(4):729. doi: 10.3390/nu17040729.
    4: Zeng W, Li H, Liu S, Luo Z, Chen J, Zhou J. Biosynthesis and bioactivities of triterpenoids from Centella asiatica: Challenges and opportunities. Biotechnol Adv. 2025 May-Jun;80:108541. doi: 10.1016/j.biotechadv.2025.108541. Epub 2025 Feb 18. 14(1):tfaf019. doi: 10.1093/toxres/tfaf019.

    合成参考文献


    摘要:
    摘要:
    摘要:Xiong Y et al; Neurochem Res Sep 19 (2008) (Epub ahead of print)
    摘要:
    摘要:
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知